Engineers Gate Manager LP Lannett CO Inc Transaction History

Engineers Gate Manager LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.75 - $1.77 $9,591 - $22,634	-12,788 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.93 $19,949 - $37,468	12,788 New	12,788 $21,000
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.83 $42,657 - $70,802	-14,659 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.17 - $5.74 $119,649 - $164,697	-28,693 Reduced 66.19%	14,659 $68,000
Q1 2021 May 17, 2021	SELL	$5.28 - $9.64 $46,495 - $84,889	-8,806 Reduced 16.88%	43,352 $229,000

Q4 2020 Feb 16, 2021	SELL	$5.75 - $7.13 $21,671 - $26,872	-3,769 Reduced 6.74%	52,158 $340,000
Q3 2020 Nov 16, 2020	SELL	$4.9 - $7.12 $110,132 - $160,029	-22,476 Reduced 28.67%	55,927 $342,000
Q2 2020 Aug 17, 2020	BUY	$6.43 - $9.86 $504,131 - $773,053	78,403 New	78,403 $569,000
Q4 2019 Feb 14, 2020	SELL	$8.49 - $12.81 $2.85 Million - $4.3 Million	-335,506 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $1.2 Million - $3.12 Million	215,540 Added 179.67%	335,506 $3.76 Million
Q2 2019 Aug 14, 2019	SELL	$5.22 - $9.08 $442,295 - $769,357	-84,731 Reduced 41.39%	119,966 $727,000
Q1 2019 May 15, 2019	BUY	$5.35 - $9.82 $1.1 Million - $2.01 Million	204,697 New	204,697 $1.61 Million
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $57,905 - $104,499	-16,882 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$4.75 - $14.5 $80,189 - $244,789	16,882 New	16,882 $80,000
Q2 2018 Aug 03, 2018	SELL	$13.3 - $17.45 $557,283 - $731,172	-41,901 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$14.7 - $24.95 $615,944 - $1.05 Million	41,901 New	41,901 $673,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.